Literature DB >> 21297602

Fecal matters.

Roxanne Palmer.   

Abstract

Mesh：

Year:  2011        PMID： 21297602     DOI： 10.1038/nm0211-150

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  10 in total

1.  Fecal enema as an adjunct in the treatment of pseudomembranous enterocolitis.

Authors:  B EISEMAN; W SILEN; G S BASCOM; A J KAUVAR
Journal:  Surgery       Date:  1958-11       Impact factor: 3.982

2.  Fecal bacteriotherapy, fecal transplant, and the microbiome.

Authors:  Martin H Floch
Journal:  J Clin Gastroenterol       Date:  2010-09       Impact factor: 3.062

3.  'Game changer' antibiotic and others in works for superbug.

Authors:  Elie Dolgin
Journal:  Nat Med       Date:  2011-01       Impact factor: 53.440

4.  Fecal flora reconstitution for recurrent Clostridium difficile infection: results and methodology.

Authors:  Faith Rohlke; Christina M Surawicz; Neil Stollman
Journal:  J Clin Gastroenterol       Date:  2010-09       Impact factor: 3.062

5.  Treatment of refractory/recurrent C. difficile-associated disease by donated stool transplanted via colonoscopy: a case series of 12 patients.

Authors:  Sonia S Yoon; Lawrence J Brandt
Journal:  J Clin Gastroenterol       Date:  2010-09       Impact factor: 3.062

6.  Bacteriotherapy for chronic relapsing Clostridium difficile diarrhoea in six patients.

Authors:  M Tvede; J Rask-Madsen
Journal:  Lancet       Date:  1989-05-27       Impact factor: 79.321

7.  Durable alteration of the colonic microbiota by the administration of donor fecal flora.

Authors:  Martin J Grehan; Thomas Julius Borody; Sharyn M Leis; Jordana Campbell; Hazel Mitchell; Antony Wettstein
Journal:  J Clin Gastroenterol       Date:  2010-09       Impact factor: 3.062

8.  Treatment of ulcerative colitis using fecal bacteriotherapy.

Authors:  Thomas J Borody; Eloise F Warren; Sharyn Leis; Rosa Surace; Ori Ashman
Journal:  J Clin Gastroenterol       Date:  2003-07       Impact factor: 3.062

9.  Changes in the composition of the human fecal microbiome after bacteriotherapy for recurrent Clostridium difficile-associated diarrhea.

Authors:  Alexander Khoruts; Johan Dicksved; Janet K Jansson; Michael J Sadowsky
Journal:  J Clin Gastroenterol       Date:  2010 May-Jun       Impact factor: 3.062

10.  Pseudomembraneous enterocolitis: mechanism for restoring floral homeostasis.

Authors:  T A Bowden; A R Mansberger; L E Lykins
Journal:  Am Surg       Date:  1981-04       Impact factor: 0.688
  10 in total
  8 in total

Review 1.  IBD and the gut microbiota--from bench to personalized medicine.

Authors:  Emanuelle Bellaguarda; Eugene B Chang
Journal:  Curr Gastroenterol Rep       Date:  2015-04

Review 2.  Intestinal colonization resistance.

Authors:  Trevor D Lawley; Alan W Walker
Journal:  Immunology       Date:  2013-01       Impact factor: 7.397

3.  Patient perceptions of fecal microbiota transplantation for ulcerative colitis.

Authors:  Stacy A Kahn; Ashley Vachon; Dylan Rodriquez; Sarah R Goeppinger; Bonnie Surma; Julia Marks; David T Rubin
Journal:  Inflamm Bowel Dis       Date:  2013-06       Impact factor: 5.325

Review 4.  Pathobionts of the gastrointestinal microbiota and inflammatory disease.

Authors:  Janet Chow; Haiqing Tang; Sarkis K Mazmanian
Journal:  Curr Opin Immunol       Date:  2011-08-17       Impact factor: 7.486

Review 5.  Benefits of short-chain fatty acids and their receptors in inflammation and carcinogenesis.

Authors:  Sathish Sivaprakasam; Puttur D Prasad; Nagendra Singh
Journal:  Pharmacol Ther       Date:  2016-04-23       Impact factor: 12.310

Review 6.  Supra-organismal interactions in the human intestine.

Authors:  Laura Glendinning; Andrew Free
Journal:  Front Cell Infect Microbiol       Date:  2014-04-23       Impact factor: 5.293

Review 7.  Healthcare providers' perception of faecal microbiota transplantation with clostridium difficile infection and inflammatory bowel disease: a quantitative systematic review.

Authors:  Yanghua Liu; Kal Alnababtah; Simon Cook; Ying Yu
Journal:  Therap Adv Gastroenterol       Date:  2021-09-20       Impact factor: 4.409

8.  Combination of Probiotics and Salvia miltiorrhiza Polysaccharide Alleviates Hepatic Steatosis via Gut Microbiota Modulation and Insulin Resistance Improvement in High Fat-Induced NAFLD Mice.

Authors:  Wei Wang; Ai Lei Xu; Zheng Chao Li; Yi Li; Shun Fu Xu; Hua Chao Sang; Fachao Zhi
Journal:  Diabetes Metab J       Date:  2019-12-03       Impact factor: 5.376
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.